Association between ENPP1 K173Q and stroke in a newborn cohort of 395 Brazilian children with sickle cell anemia

Blood

Volumn 126, Issue 10, 2015, Pages 1259-1260

  Belisário, André Rolim ^a,b   Sales, Rahyssa Rodrigues ^a,b   Toledo, Nayara Evelin ^a   Velloso Rodrigues, Cibele ^c   Silva, Célia Maria ^a   Viana, Marcos Borato ^b  

^a FUNDAÇÃO HEMOMINAS   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; NITRIC OXIDE SYNTHASE; INORGANIC PYROPHOSPHATASE; MEMBRANE PROTEIN; PHOSPHODIESTERASE;

ADOLESCENT; ALLELE; BRAZILIAN; CEREBROVASCULAR ACCIDENT; CHILD; CLINICAL EVALUATION; COHORT ANALYSIS; ELEVATED BLOOD PRESSURE; ENPP1 GENE; GENE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GOLGB1 GENE; HIGH RISK PATIENT; HUMAN; INSULIN RESISTANCE; LETTER; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; NEWBORN; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROBABILITY; RETICULOCYTE COUNT; RISK ASSESSMENT; RISK FACTOR; SICKLE CELL ANEMIA; TRANSCRANIAL DOPPLER; COMPLICATION; GENETICS; SINGLE NUCLEOTIDE POLYMORPHISM; STROKE;

ANEMIA, SICKLE CELL; HUMANS; MEMBRANE PROTEINS; PHOSPHORIC DIESTER HYDROLASES; POLYMORPHISM, SINGLE NUCLEOTIDE; PYROPHOSPHATASES; STROKE;

EID: 84942512629     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2015-05-645176     Document Type: Letter

References (12)

1. Bernaudin F, Verlhac S, Arnaud C, et al. Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort. Blood. 2011;117(4):1130-1140.
2. Adams RJ, McKie VC, Carl EM, et al. Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler. Ann Neurol. 1997;42(5):699-704.
3. Flanagan JM, Sheehan V, Linder H, et al. Genetic mapping and exome sequencing identify 2 mutations associated with stroke protection in pediatric patients with sickle cell anemia. Blood. 2013;121(16):3237-3245.
4. Goldfine ID, Maddux BA, Youngren JF, et al. The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities. Endocr Rev. 2008;29(1):62-75.
5. Bacci S, Rizza S, Prudente S, et al. The ENPP1 Q121 variant predicts major cardiovascular events in high-risk individuals: evidence for interaction with obesity in diabetic patients. Diabetes. 2011;60(3):1000-1007.
6. McAteer JB, Prudente S, Bacci S, et al; ENPP1 Consortium. The ENPP1 K121Q polymorphism is associated with type 2 diabetes in European populations: evidence from an updated meta-analysis in 42,042 subjects. Diabetes. 2008;57(4):1125-1130.
7. Bacci S, Di Paola R, Menzaghi C, et al. ENPP1 Q121 variant, increased pulse pressure and reduced insulin signaling, and nitric oxide synthase activity in endothelial cells. Arterioscler Thromb Vasc Biol. 2009;29(10):1678-1683.
8. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998;91(1):288-294.
9. Hoppe C, Klitz W, Cheng S, et al; CSSCD Investigators. Gene interactions and stroke risk in children with sickle cell anemia. Blood. 2004;103(6):2391-2396.
10. Choi Y, Sims GE, Murphy S, Miller JR, Chan AP. Predicting the functional effect of amino acid substitutions and indels. PLoS One. 2012;7(10):e46688.
11. Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4(7):1073-1081.
12. Wang X, Cheng S, Brophy VH, et al; RMS Stroke SNP Consortium. A meta-analysis of candidate gene polymorphisms and ischemic stroke in 6 study populations: association of lymphotoxin-alpha in nonhypertensive patients. Stroke. 2009;40(3):683-695.